JCM
BLFS icon

Jacobi Capital Management’s BioLife Solutions BLFS Stock Holding History

Jacobi Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100
Closed -$4K – 1440
2021
Q2 		$4K Hold
100
– – ﹤0.01% 1179
2021
Q1 		$4K Hold
100
– – ﹤0.01% 1140
2020
Q4 		$4K Hold
100
– – ﹤0.01% 1035
2020
Q3 		$3K Buy
+100
New +$2.16K ﹤0.01% 1019

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Jacobi Capital Management's BLFS Position: Q3 2021 in Review

Jacobi Capital Management sold out of BioLife Solutions (BLFS) in Q3 2021, closing a stake of 100 shares — an estimated $4K sold.

Jacobi Capital Management first reported a position in BLFS in Q3 2020 and held it in 4 quarters. The position peaked at $4K in Q2 2021. 165 funds tracked by Wall St. Rank hold BLFS as of Q3 2021.

  • Jacobi Capital Management reported no remaining BioLife Solutions position as of Q3 2021 after selling out during the quarter.
  • Jacobi Capital Management sold 100 BioLife Solutions shares in Q3 2021, an estimated $4K.
  • Jacobi Capital Management first reported a position in BioLife Solutions in Q3 2020 and held it in 4 quarters.
  • Jacobi Capital Management's BioLife Solutions position peaked at $4K in Q2 2021.
  • 165 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2021.

Based on Jacobi Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.